ClinicalTrials.Veeva

Menu

Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)

Loma Linda University (LLU) logo

Loma Linda University (LLU)

Status

Enrolling

Conditions

Cesarean Section Complications
Cesarean Section; Infection

Treatments

Device: Irrisept
Drug: Normal Saline

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06339203
5240002

Details and patient eligibility

About

This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.

Enrollment

400 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 or older
  • Singleton pregnancy
  • Planned cesarean delivery at gestational age 37 weeks or later at Loma Linda University Children's Hospital
  • Planned post-operative follow up with Loma Linda OBGYN
  • Speak English or Spanish
  • At least one of the following medical complications: Obesity BMI>= 30kg/m2, Diabetes, Spontaneous rupture of membranes, Intraamniotic infection

Exclusion criteria

  • Emergency cesarean delivery

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

Irrisept
Experimental group
Description:
The experimental arm will receive irrigation solution Irrisept administered through a proprietary bottle (jet lavage) following the closure of the fascia in Cesarean section.
Treatment:
Device: Irrisept
Normal Saline
Active Comparator group
Description:
The active comparator arm will receive the standard of care irrigation solution, normal saline, administered via standard pour over following the closure of the fascia in Cesarean section.
Treatment:
Drug: Normal Saline

Trial contacts and locations

1

Loading...

Central trial contact

Nikia Gray-Hutto, AS; Ashra Denise Tugung, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems